lower GI pharmacology Flashcards

1
Q

Constipation

A

Multiple causes- lack of dietary fiber, drugs, hormonal , neurogenic or emotional disorders, illness

Laxatives- enhance the retention of intraluminal fluid in stool, decrease absorption or increase secretion of fluid by gut wall, increase propulsive motility

increases fluid–> increased stretch–> increased propulsions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

dietary fiber- laxatives

A

food that resists enzymatic digestion- unfermented fiber attracts water (lignin)- Bran, fruits and veggies are more easily fermented and draw less water

Synthetic celluloses - Psyllium (metamucil), Methylcellulose (citrucel)

Effects– bloating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

laxatives- osmotic agents

A

Saline laxatives- Magnesium citrate, magesium hydroxide

MOA: Osmotic water retention, increased volume promotes peristalsis

SE: caution with renal insufficiency, cardiac disease, diuretics or electrolyte abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Non digestable sugars-osmotic laxatives

A

Lactulose

Hydrolyzed to short chain fatty acids in the colon biota, osmotically drawing water into the lumin

Use for opiod induced constipation, old constipation, idiopathic, portal system encephalopathy (increased excretion of ammonia), acidifies

sE: gas and cramping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

osmotic agents other

A
polyethylene glycol-  poorly absorbed, retain water due to osmosis
Colonic cleansing (w/ electrolytes-- pre surgery), occasional constipation

Docusate salts- surfactan that increases the water content of stool, Therapeutic use, mild constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stimulant laxatives

A

Stimulant/irritant laxatives

MOA: induce giant migrating colonic contractions, water and electrolyte secretion

Bisacodyl- prodrug, requires hydrolysis by endogenous esterases in the bowel – 6 hours

Senna- plant- prodrug, activated in the colon, SE- diarrhea, abdominal pain, hypokalemia (chronic use), dependency

Abuse for losing wt, atonic colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Laxatives- prostaglandin analog

A

Lubiprostane-
Chronic idiopathic constipation, opiod-constipation, IBS

MOS: prostaglandin analog, activates CL channels, increased water in lumen

Side effects- nausea, diarrhea, headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

opiod constipation

A

Mu receptor activation–>
Inhibit peristalsis
Increase sphincter
Increase fluid absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Opiod receptor antagonist- laxative

A

MEthylnaltrexone- blocks mu opiod receptor, prevents suppression of peristalsis
Therapeutic use- after conventional laxatives, opiod induced constipation

SE: contraindicated with GI obstruction, abdominal pain

Does not cross BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diarrhea

A

Causes of diarrhea-
Osmotic load, retention of water in the lumen
Excessive secretion of electrolytes and water
Exudation of protein and fluid from the mucosa

Dehydration and electrolyte imbalance are the main risk in severe cases of diarrhea

A balanced mixture of glucose and salts can prevent dehydration because sodium and chloride absorption is linked to glucose uptake followed by movement of water

Pharm therapy is best reserved for pts with significat and/or persistant symptoms, anitdiarrheal agents provide symptomatic relief but do not treat the underlying cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bismuth subsalicylate

A

Travelers diarrhea, episodic diarrhea and acute gastroenteritis, infection

MOA: antisecretory, anti-inflammatory, and antimicrobial, bismuth passes unabsorbed into the feces, salicylate is absorbed in the stomach and small intestine

SE: dark stool, black hairy tongue, warning regarding REye’s syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anti diarrheal agen

A

Probiotics/ fecal transplant

MOA: gut recolonization with non-pathogenic bacteria
Acute diarrheal conditions, antibiotic associated diarrhea, and infectious diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Opiod derivatives

A

Loperamide (imodium)- over the counter, mu receptor agonis, poor CNS penetration
Diphenoxylate- mu receptor agonist, CNS penetration, may combine with atropine

Effective against travelers diarrhea, and chronic diarrheal disesase,

MOA: inhibit peristalsis and prolong transit time, increases visocosity

SE: Abdominal pain, constipation, overdose–> CNS depression, and paralytic ileus, risk for toxic megacolon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Octreotide

A

Somatostatin analog

MOA: Inhibits hormone secretion from tumors, including 5HT, gastrin, VIP

USe: hormone secreting carcinoid tumors of the pancreas and GIT, dumping syndrome, following gastric surgery

SE: nausea, gallstone formation, hypo/hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

IBS

A

Chronic disorder of the characterized by abdominal pain and altered bowel habits in the absence of an organic disease

Etiology of IBS is poorly understood- motility, visceral hypersensitivity

Treatment- dietary modifications
Constipation IBS- Lubiprostone
Diarrhea-hypscyamine, alosetron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hyoscyamine

A

MOA: muscarinic antagonist, decrease smooth muscle contractions

USE- adjuvant thearpy IBS-D, divertivulitis, colic

SE: dry mouth, urinary retention, palpitations

17
Q

Alosetron

A

5ht3 antagonist, decreases GI contractility, increase colontic transit time

Improvements in abdominal pain, stool frequency and consistency, may also blunt visceral sensation

Use- Women with IBS-d who have not responded to convetional therapy, (concern for ischemic colitis)

18
Q

Pathogenesis of IBD

A

disruption of epithelial barrier, bacteria go to DCs, Dcs–activate helper T cells– TNF a release– activation of macrophage–> postitive feedback

IL12 also releasede

19
Q

IBD goals of therapy

A

Relief of symptoms (acute attacks), induction of remission , precention of relapse, treats the complications (fistulas)

5 aminosalicylates, corticosteroids, Immunosuppressive agents, biologics, Jak kinase inhibitor

20
Q

5 aminosalicylates

A

Sulfasalaine- prodrug activated by colonic bacteria, SE- headache, nausea, dizziness (5 ASA thrp, sulfapyridine)

Mesalamine- delayed release formulation, pH sensitive coating, SE- infrequent, headache and rash

Osalazine- dimer of 2 mesalamines, bacteria cleave in distal portion of gut

MOA- unclear, inhibitionof IL1, TNFa and lipoxygenase pathway, no COx inhibition

USe for mild to moderate ulcerative colitis

21
Q

Corticosteroids

A

Prednisone- most common
Budesonide- enteric release synthetic steroid use for mild to moderate crohns disease, low F delivers therapy to bowel while minimizing side effects

Therapy- Induce remission in all type of UC or Crohns

MOA- dampen the inflammatory response, decrease ILs and TNFa

SE- systemic effects, wt gain, emothional and sleep disturbances glaucoma

22
Q

Immunosuppressive agents

A

AKA Thipurine derivatives

6- MC
Azathioprine

MOA- impair purine biosynthesis and inhibit cell proliferation
Theraputic use- Crohns and UC (maintain remission), Crohns releated fistulas

SE- bone marrow supression, vomiting, jaundice, pancreatitis

23
Q

Methotrexate

A

MOA- irreversibly inhibits DHF reductase, blocking DNA synthesis, repair, proliferation and causing cell death
Anti inflammatory

USe- steroid resistant or steroid dependent IBD (Crohns- induces and maintains remission

X preg

24
Q

Infliximab

A

IV Ig, Neutralizes TNF a

Use- UC and Crohns, closes fistulas, deceases acute flates, maintains remission

SE- respiratory tract infection, reactivation of TB

Contraindicated in pts with severe congestive HF

Ab against infliximab, combined with azathioprine

Adalimumab and Certolizumab also TNFa against , mod to severe crohns

25
Q

natalizumab and vedolizumab

A

Ab inhibits Alpha 4 integrins
MOA: reduces extravasion of lymphocytes to sites of inflammation
USe- mod to severe crohns
SE- upper respiratory infection, hypersensitivity reaction, hepatotoxivity
ContInd with immune modulating drugs, multifocal leukoencephalopathy

26
Q

ustekinumab

A

IL12 andIL 23 antagonist

prevents activation of lymphocytes

SE- infectionarthralgia